THRB and metabolic dysfunction-associated steatohepatitis: In the liver, local TRβ action lowers lipid content, thus offering a therapeutic potential of TH action in the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).